The emergence of multidrug-resistant Klebsiella pneumoniae of international clones ST13, ST16, ST35, ST48 and ST101 in a teaching hospital in the Paris region

Epidemiology and Infection

Volumn 141, Issue 8, 2013, Pages 1705-1712

  Marcade, G ^a   Brisse, S ^b   Bialek, S ^c,d,e   Marcon, E ^c   Leflon Guibout, V ^c   Passet, V ^b   Moreau, R ^e   Nicolas Chanoine, M H ^c,d,e  

^a HÔPITAL LOUIS MOURIER   (France)

^b INSTITUT PASTEUR   (France)

^c BEAUJON HOSPITAL   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e CENTRE DE RECHERCHE BIOMÉDICALE BICHAT BEAUJON CRB3   (France)

Author keywords

Antibiotic resistance; hospital acquired (nosocomial) infections; infectious disease epidemiology; Klebsiella; molecular epidemiology

Indexed keywords

ANTIBIOTIC AGENT; ARGININE; BETA LACTAMASE CTX M; CEFOTAXIME; EXTENDED SPECTRUM BETA LACTAMASE; SERINE;

ABSCESS; ANTIBIOTIC RESISTANCE; ARTICLE; ASCITES; BACTERIAL STRAIN; BACTERIUM CARRIER; BACTERIUM CONTAMINATION; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BLOOD CULTURE; CATHETER; ENZYME ASSAY; FECES; FRANCE; GENE SEQUENCE; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MOLECULAR CLONING; MOLECULAR EPIDEMIOLOGY; MULTIDRUG RESISTANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; SEQUENCE ANALYSIS; TEACHING HOSPITAL; URINE; WARD;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HOSPITALS, TEACHING; HUMANS; INCIDENCE; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MULTILOCUS SEQUENCE TYPING; PARIS; POLYMERASE CHAIN REACTION;

EID: 84880395262     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268812002099     Document Type: Article

References (37)

1. Cantón R, et al. Prevalence and spread of extendedspectrum beta-lactamase-producing Enterobacteriaceae in Europe. Clinical Microbiology and Infection 2008; 14 (Suppl. 1): 144-153.
2. Jarlier V, et al. Extended broad-spectrum betalactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: Hospital prevalence and susceptibility patterns. Reviews of Infectious Diseases 1988; 10: 867-878.
3. Brun-Buisson C, et al. Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae. Lancet 1987; 2: 302-306.
4. Walsh TR. Clinically significant carbapenemases: An update. Current Opinion in Infectious Diseases 2008; 21: 367-371.
5. Woodford N, Turton JF, Livermore DM. Multiresistant Gram-negative bacteria: The role of high-risk clones in the dissemination of antibiotic resistance. FEMS Microbiology Reviews 2011; 35: 736-755.
6. Nicolas-Chanoine M-H, et al. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. Journal of Antimicrobial Chemotherapy 2008; 61: 273-281.
7. Breurec S, et al. Klebsiella pneumoniae resistant to thirdgeneration cephalosporins in five African and two Vietnamese major towns: Multiclonal population structure with two major international clonal groups, CG15 and CG258. Clinical Microbiology and Infection. Published online: 15 February 2012. doi:10.1111/j.1469-0691.2012.03805.x.
8. Leflon-Guibout V, et al. Emergence and spread of three clonally related virulent isolates of CTX-M-15-producing Escherichia coli with variable resistance to aminoglycosides and tetracycline in a French geriatric hospital. Antimicrobial Agents and Chemotherapy 2004; 48: 3736-3742.
9. Diancourt L, et al. Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. Journal of Clinical Microbiology 2005; 43: 4178-4182.
10. Damjanova I, et al. Expansion and countrywide dissemination of ST11, ST15 and ST147 ciprofloxacinresistant CTX-M-15-type beta-lactamase-producing Klebsiella pneumoniae epidemic clones in Hungary in 2005-the new 'MRSAs' ? Journal of Antimicrobial Chemotherapy 2008; 62: 978-985.
11. Peirano G, et al. Molecular epidemiology of extendedspectrum-beta- lactamase-producing Klebsiella pneumoniae over a 10 year period in Calgary, Canada. Journal of Antimicrobial Chemotherapy 2012; 67: 1114-1120.
12. Lee MY, et al. High prevalence of CTX-M-15-producing Klebsiella pneumoniae isolates in Asian countries: Diverse clones and clonal dissemination. International Journal of Antimicrobial Agents 2011; 38: 160-163.
13. Ruiz de Alegría C, et al. Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases in Spain: Microbiological and clinical features. Journal of Clinical Microbiology 2011; 49: 1134-1136.
14. Valverde A, et al. Complex molecular epidemiology of extended-spectrum beta-lactamases in Klebsiella pneumoniae: A long-term perspective from a single institution in Madrid. Journal of Antimicrobial Chemotherapy 2008; 61: 64-72.
15. Gaillot O, et al. Nosocomial outbreak of Klebsiella pneumoniae producing SHV-5 extended-spectrum betalactamase, originating from a contaminated ultrasonography coupling gel. Journal of Clinical Microbiology 1998; 36: 1357-1360.
16. Gastmeier P, et al. A cluster of nosocomial Klebsiella pneumoniae bloodstream infections in a neonatal intensive care department: Identification of transmission and intervention. American Journal of Infection Control 2003; 31: 424-430.
17. Blanco M, et al. Molecular epidemiology of Escherichia coli producing extended-spectrum beta-lactamases in Lugo (Spain): Dissemination of clone O25b:H4-ST131 producing CTX-M-15. Journal of Antimicrobial Chemotherapy 2009; 63: 1135-1141.
18. Lytsy B, et al. The first major extended-spectrum betalactamase outbreak in Scandinavia was caused by clonal spread of a multiresistant Klebsiella pneumoniae producing CTX-M-15. Acta Pathologica, Microbiologica, et Immunologica Scandinavica 2008; 116: 302-308.
19. Nielsen JB, et al. Identification of CTX-M15-, SHV-28-producing Klebsiella pneumoniae ST15 as an epidemic clone in the Copenhagen area using a semiautomated Rep-PCR typing assay. European Journal of Clinical Microbiology & Infectious Diseases 2011; 30: 773-778.
20. Lester CH, et al. Emergence of extended-spectrum beta-lactamase (ESBL)-producing Klebsiella pneumoniae in Danish hospitals; this is in part explained by spread of two CTX-M-15 clones with multilocus sequence types 15 and 16 in Zealand. International Journal of Antimicrobial Agents 2011; 38: 180-182.
21. Seki LM, et al. Molecular epidemiology of KPC-2-producing Klebsiella pneumoniae isolates in Brazil: The predominance of sequence type 437. Diagnostic Microbiology and Infectious Disease 2011; 70: 274-277.
22. Andrade LN, et al. Dissemination of blaKPC-2 by the spread of Klebsiella pneumoniae clonal complex 258 clones (ST258, ST11, ST437) and plasmids (IncFII, IncN, IncL/M) among Enterobacteriaceae species in Brazil. Antimicrobial Agents and Chemotherapy 2011; 55: 3579-3583.
23. Oteo J, et al. Emergence of CTX-M-15-producing Klebsiella pneumoniae of multilocus sequence types 1, 11, 14, 17, 20, 35 and 36 as pathogens and colonizers in newborns and adults. Journal of Antimicrobial Chemotherapy 2009; 64: 524-528.
24. Diestra K, et al. Multiclonal epidemic of Klebsiella pneumoniae isolates producing DHA-1 in a Spanish hospital. Clinical Microbiology and Infection 2011; 17: 1032-1036.
25. Giakkoupi P, et al. An update of the evolving epidemic of blaKPC-2-carrying Klebsiella pneumoniae in Greece (2009-10). Journal of Antimicrobial Chemotherapy 2011; 66: 1510-1513.
26. Brisse S, et al. Virulent clones of Klebsiella pneumoniae: Identification and evolutionary scenario based on genomic and phenotypic characterization. PLoS One 2009; 4: E4982.
27. Elhani D, et al. Molecular epidemiology of extendedspectrum beta-lactamase-producing Klebsiella pneumoniae strains in a university hospital in Tunis, Tunisia, 1999-2005. Clinical Microbiology and Infection 2010; 16: 157-164.
28. Cuzon G, et al. Outbreak of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in France. Antimicrobial Agents and Chemotherapy 2011; 55: 2420-2423.
29. Pitart C, et al. First outbreak of a plasmid-mediated carbapenem-hydrolyzing OXA-48 beta-lactamase in Klebsiella pneumoniae in Spain. Antimicrobial Agents and Chemotherapy 2011; 55: 4398-4401.
30. Adler A, et al. Introduction of OXA-48-producing Enterobacteriaceae to Israeli hospitals by medical tourism. Journal of Antimicrobial Chemotherapy 2011; 66: 2763-2766.
31. Hrabák J, et al. International clones of Klebsiella pneumoniae and Escherichia coli with extendedspectrum beta-lactamases in a Czech hospital. Journal of Clinical Microbiology 2009; 47: 3353-3357.
32. Kitchel B, et al. Molecular epidemiology of KPCproducing Klebsiella pneumoniae isolates in the United States: Clonal expansion of multilocus sequence type 258. Antimicrobial Agents and Chemotherapy 2009; 53: 3365-3370.
33. Ko KS, et al. Predominance of an ST11 extendedspectrum beta-lactamase-producing Klebsiella pneumoniae clone causing bacteraemia and urinary tract infections in Korea. Journal of Medical Microbiology 2010; 59: 822-828.
34. Shin J, Kim DH, Ko KS. Comparison of CTX-M-14-and CTX-M-15-producing Escherichia coli and Klebsiella pneumoniae isolates from patients with bacteremia. Journal of Infection 2011; 63: 39-47.
35. Coelho A, et al. Detection of three stable genetic clones of CTX-M-15-producing Klebsiella pneumoniae in the Barcelona metropolitan area, Spain. Journal of Antimicrobial Chemotherapy 2009; 64: 862-864.
36. Leavitt A, et al. Molecular epidemiology, sequence types, and plasmid analyses of KPC-producing Klebsiella pneumoniae strains in Israel. Antimicrobial Agents and Chemotherapy 2010; 54: 3002-3006.
37. Leflon-Guibout V, et al. Absence of CTX-M enzymes but high prevalence of clones, including clone ST131, among fecal Escherichia coli isolates from healthy subjects living in the area of Paris, France. Journal of Clinical Microbiology 2008; 46: 3900-3905.